News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Oscar Tahuahua: Advances in Molecular Pathology and Therapy of NSCLC
Oscar Tahuahua/X
Jun 16, 2025, 11:26

Oscar Tahuahua: Advances in Molecular Pathology and Therapy of NSCLC

Oscar Tahuahua, Medical Oncology fellow at the National Cancer Institute of Mexico, shared a post on X:

“Advances in Molecular Pathology and Therapy of NSCLC.
Precision oncology is no longer optional. This review maps the molecular landscape of NSCLC (EGFR, ALK, KRAS, etc.), resistance, spatial omics and AI, and shows how biology is reshaping lung cancer treatment.
Resistance in NSCLC isn’t accidental, it’s adaptive. This explains how EGFR T790M, KRAS/STK11, EMT and an immunosuppressive TME reshape tumor biology under treatment pressure.”

Title: Advances in molecular pathology and therapy of non-smallcell lung cancer

Authors: Qing Huang, Yuanxiang Li, Yingdan Huang, Jingyi Wu, Wendai Bao, Chang Xue, Xiaoyu Li, Shuang Dong, Zhiqiang Dong, Sheng Hu

Read The Full Article at Signal Transduction and Targeted Therapy.

Oscar Tahuahua: Advances in Molecular Pathology and Therapy of NSCLC

More posts featuring Oscar Tahuahua on OncoDaily.

cancer Chang Xue Jingyi Wu lung cancer treatment NSCLC OncoDaily Oncology Oscar Tahuahua Precision Oncology Qing Huang Sheng Hu Shuang Dong Wendai Bao Xiaoyu Li Yingdan Huang Yuanxiang Li Zhiqiang Dong
Special Coverage
Voices
Aug 16, 2025, 16:56
Strengthening National Cancer Control Plans for Equitable Care - UICC
Voices
Aug 16, 2025, 16:41
Meet the Researchers: Lekha Mikkilineni - Conquer Cancer, the ASCO Foundation
Positive
Aug 16, 2025, 16:28
Ebony Boulware: Honored to Join the Investiture of Joshua Patt as Inaugural Endowed Chair for Sarcoma Research
Drugs
Aug 16, 2025, 16:14
Cemiplimab-rwlc (Libtayo) Updates 2025: Uses in cancer, Side effects, Dosage, Expectations and more
Voices
Aug 16, 2025, 15:59
Sigrun Hallmeyer: Honored to be Recognized With CWC Impact Award
Voices
Aug 16, 2025, 15:58
Comprehensive Agenda for AdventHealth Cancer Institute's 12th Annual Officially Licensed Best of ASCO
Voices
Aug 16, 2025, 15:56
Winette van der Graaf: Long-term Survival of AYA Solid Cancer Survivors Supports Changes to Right To Be Forgotten Laws
Insight
Aug 16, 2025, 15:55
John H. Stewart IV: First Completed Randomized Trial with Oncologic Endpoints for Appendiceal Cancer
Insight
Aug 16, 2025, 15:53
NIH Researchers Explore ERVs as Promising Cancer Targets
Voices
Aug 16, 2025, 15:50
Chuck Stravin: From Patient to Advocate - Why the Jimmy Fund Telethon Matters
Voices
Aug 16, 2025, 15:49
Registration Is Open for the 2025 ESGO-ENYGO Masterclass in Tbilisi
Voices
Aug 16, 2025, 15:42
Amanda P: Colorectal Cancer Alliance is Looking for a VP of Corporate Partnerships at Colorectal Cancer Alliance